NDC Code(s) : 69189-0223-1
Packager : Avera McKennan Hospital

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

CilostazolCilostazol TABLET
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69189-0223(NDC:0185-0223)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CILOSTAZOL(UNII: N7Z035406B)
(CILOSTAZOL - UNII:N7Z035406B) 		CILOSTAZOL100 mg
Inactive Ingredients
Ingredient Name Strength
CARBOXYMETHYLCELLULOSE CALCIUM(UNII: UTY7PDF93L)
MAGNESIUM STEARATE(UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE(UNII: OP1R32D61U)
STARCH, CORN(UNII: O8232NY3SJ)
METHYLCELLULOSE (15 MPA.S)(UNII: NPU9M2E6L8)
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 9 mm
Flavor Imprint Code E;223
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:69189-0223-11 in 1 DOSE PACK Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077021 04/01/2015

PRINCIPAL DISPLAY PANEL

Cilostazol 100 mg tablet label